Friday, biopharmaceutical company Auxilium Pharmaceuticals Inc. (AUXL), said it has priced an underwritten initial public offering of 3 million shares of its common stock. The company also granted the underwriters a 30-day option to purchase up to 450 thousand shares to cover over-allotments, if any. The sale is expected to settle close on September 30, 2009, subject to customary closing conditions.
Jefferies & Company is acting as sole book-running manager in this offering.
For comments and feedback: editorial@rttnews.com